STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its upcoming participation in the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Monday, January 13, 2025, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).

Investors and interested parties can access a live webcast of the presentation through the Investors section of Kiniksa's website at www.kiniksa.com. Additionally, a replay of the presentation will be made available on the company's website within approximately 48 hours following the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

LONDON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).

A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts! ®

Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com

Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com


FAQ

When is Kiniksa Pharmaceuticals (KNSA) presenting at the J.P. Morgan Healthcare Conference 2025?

Kiniksa Pharmaceuticals will present on Monday, January 13, 2025, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).

How can investors watch KNSA's presentation at the J.P. Morgan Healthcare Conference?

Investors can watch the live webcast through the Investors section of Kiniksa's website at www.kiniksa.com.

When will the replay of KNSA's J.P. Morgan Healthcare Conference presentation be available?

A replay of the presentation will be available on Kiniksa's website within approximately 48 hours after the event.

Which annual J.P. Morgan Healthcare Conference is KNSA presenting at in 2025?

Kiniksa Pharmaceuticals is presenting at the 43rd Annual J.P. Morgan Healthcare Conference.
Kiniksa Pharmaceuticals International, plc

NASDAQ:KNSA

KNSA Rankings

KNSA Latest News

KNSA Latest SEC Filings

KNSA Stock Data

3.22B
43.64M
3.74%
92.97%
3.65%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United Kingdom
LONDON